CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4/A Grant or award Director acquired 66,218 shares (grant or award)
- 4 Grant or award Director acquired 70,467 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 70,113 shares (grant or award)
- 4 Grant or award Director acquired 66,218 shares (grant or award)
- 4 Grant or award Director acquired 84,986 shares (grant or award)
- 4 Grant or award Director acquired 65,156 shares (grant or award)
- 8-K Event Material agreement
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Delisting notice
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.71 ($3,542)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Delisting notice
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13D/A Stake Beneficial Ownership Report
Page 26 of 78 · 1,549 filings